Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Am J Transplant. 2021 Mar 17;21(9):3066–3076. doi: 10.1111/ajt.16538

Table 2.

Primary outcome: renal function

n q1m n q2m
Unadjusted
 eGFRb, mean at baseline (SD) 82 72.43 (17.70) 81 69.25 (16.41)
 eGFR12, mean at 12 months (SD) 76 74.11 (18.25) 77 70.69 (16.66)
 Change in eGFR (eGFR12 – eGFRb) - 1.24 (9.86) - 1.12 (8.14)
Mean 95% CI
 Difference in eGFR12 (q1m – q2m) 3.41 −2.17, 9.00
Adjusted (for baseline)
 eGFR12, mean at 12 months (95% CI) 76 72.65 (70.64, 74.65) 77 72.13 (70.14, 74.12)
Mean 95% CI
 Difference in eGFR12 (q1m – q2m) 0.52 −2.32, 3.35

eGFR, estimated glomerular filtration rate (ml/min/1.73m2)